Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer

被引:0
|
作者
Kayano, Hajime [1 ]
Mamuro, Nana [1 ]
Kamei, Yutaro [1 ]
Ogimi, Takashi [1 ]
Miyakita, Hiroshi [1 ]
Kanatani, Yasuhiro [2 ]
Mori, Masaki [1 ]
Okada, Kenichi [1 ]
Koyanagi, Kazuo [1 ]
Yamamoto, Seiichiro [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Gastroenterol Surg, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa, Japan
关键词
Colon cancer; body composition; perioperative period; skeletal muscle loss; adjuvant chemotherapy; LEAN BODY-MASS; ADJUVANT CHEMOTHERAPY; NUTRITIONAL-STATUS; GASTRIC-CANCER; GASTRECTOMY; SURGERY; DETERMINANT; ILEOSTOMY; ADULTS; S-1;
D O I
10.21873/anticanres.17231
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Postoperative changes in body composition, especially loss of muscle mass, often occur in gastrointestinal cancer patients. Few studies have reported perioperative changes in the body composition of patients with colorectal cancer. Therefore, this study aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. Patients and Methods: This prospective observational study included 148 patients who underwent robot- or laparoscopic-assisted surgery for colorectal cancer. Results: The rate of change in body composition at discharge was - 6.25% for body fat, with a higher rate of decrease than that for skeletal muscle mass (-3.30%; - 3.30%; p=0.0006) and body water mass (-2.66%; - 2.66%; p=0.0001). Similarly, even at one month postoperatively, body fat mass (-8.05%) - 8.05%) was reduced at a greater rate than skeletal muscle mass (-2.02% - 2.02% p=0.0001) and body water mass (-1.33% - 1.33% p=0.0001).The site-specific percent change in limb skeletal and trunk muscle mass at discharge was the greatest in the lower extremities at - 5.37%, but one month after surgery, the upper extremities had the greatest change at - 4.44%. The Prognostic Nutritional Index (PNI) influenced skeletal muscle mass loss at discharge [odds ratio (OR)=2.6; 95% confidence interval (CI)=1.30-5.58], while diabetes (OR=4.1; 95%CI=1.40-12.43) and ileostomy (OR=6.7; 95%CI=1.45-31.11) influenced skeletal muscle loss one month postoperatively. Conclusion: Preoperative and postoperative nutritional guidance/intervention and body part-specific rehabilitation should be provided to prevent skeletal muscle mass loss in patients with low PNI, diabetes, and those undergoing ileostomy.
引用
收藏
页码:4019 / 4029
页数:11
相关论文
共 50 条
  • [21] Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival
    R. Ghinea
    R. Greenberg
    I. White
    E. Sacham-Shmueli
    H. Mahagna
    S. Avital
    Techniques in Coloproctology, 2013, 17 : 549 - 554
  • [22] Factors Associated with Sarcopenia in Patients with Colorectal Cancer
    de Souza, Bianca Umbelino
    Silva Souza, Nilian Carla
    Martucci, Renata Brum
    Rodrigues, Viviane Dias
    de Pinho, Nivaldo Barroso
    Gonzalez, Maria Cristina
    Avesani, Carla Maria
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2018, 70 (02): : 176 - 183
  • [23] Factors Associated with Distress in Colorectal Cancer Patients
    Fahy, Bridget N.
    Ratmeyer, Paul
    Guo, Yan
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 481 - 481
  • [24] Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102
    Hacioglu, Muhammet Bekir
    Kostek, Osman
    Kurt, Nazmi
    Kucukarda, Ahmet
    Gokyer, Ali
    Ustabasioglu, Fethi Emre
    Karatas, Fatih
    Tuncbilek, Nermin
    Uzunoglu, Sernaz
    Bilici, Ahmet
    Cicin, Irfan
    Erdogan, Bulent
    JOURNAL OF BUON, 2019, 24 (05): : 2198 - 2204
  • [25] Preoperative skeletal muscle status is associated with tumor-infiltrating lymphocytes and prognosis in patients with colorectal cancer
    Daitoku, Nobuya
    Miyamoto, Yuji
    Hiyoshi, Yukiharu
    Tokunaga, Ryuma
    Sakamoto, Yuki
    Sawayama, Hiroshi
    Ishimoto, Takatsugu
    Baba, Yoshifumi
    Yoshida, Naoya
    Baba, Hideo
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2022, 6 (05): : 658 - 666
  • [26] Risk Factors Associated with Anastomotic Leakage in Colorectal Cancer
    Xiaojiang Yi
    Yueming Huang
    Yulong He
    Chuangqi Chen
    Indian Journal of Surgery, 2019, 81 : 154 - 163
  • [27] Perioperative factors associated with hidden blood loss in intertrochanteric fracture patients
    Liu Y.
    Sun Y.
    Fan L.
    Hao J.
    MUSCULOSKELETAL SURGERY, 2017, 101 (2) : 139 - 144
  • [28] Risk Factors Associated with Anastomotic Leakage in Colorectal Cancer
    Yi, Xiaojiang
    Huang, Yueming
    He, Yulong
    Chen, Chuangqi
    INDIAN JOURNAL OF SURGERY, 2019, 81 (02) : 154 - 163
  • [29] Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer
    Babic, Ana
    Rosenthal, Michael H.
    Bamlet, William R.
    Takahashi, Naoki
    Sugimoto, Motokazu
    Danai, Laura V.
    Morales-Oyarvide, Vicente
    Khalaf, Natalia
    Dunne, Richard F.
    Brais, Lauren K.
    Welch, Marisa W.
    Zellers, Caitlin L.
    Dennis, Courtney
    Rifai, Nader
    Prado, Carla M.
    Caan, Bette
    Sundaresan, Tilak K.
    Meyerhardt, Jeffrey A.
    Kulke, Matthew H.
    Clish, Clary B.
    Ng, Kimmie
    Vander Heiden, Matthew G.
    Petersen, Gloria M.
    Wolpin, Brian M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (12) : 2062 - 2069
  • [30] Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss
    Best, Till Dominik
    Roeland, Eric J.
    Horick, Nora K.
    Van Seventer, Emily E.
    El-Jawahri, Areej
    Troschel, Amelie S.
    Johnson, Patrick C.
    Kanter, Katie N.
    Fish, Madeleine G.
    Marquardt, J. Peter
    Bridge, Christopher P.
    Temel, Jennifer S.
    Corcoran, Ryan B.
    Nipp, Ryan D.
    Fintelmann, Florian J.
    ONCOLOGIST, 2021, 26 (06): : E963 - E970